Annual CFI
-$329.70 K
-$57.30 K-21.04%
December 31, 2023
Summary
- As of February 7, 2025, BDRX annual cash flow from investing activities is -$329.70 thousand, with the most recent change of -$57.30 thousand (-21.04%) on December 31, 2023.
- During the last 3 years, BDRX annual CFI has fallen by -$3.63 million (-109.98%).
- BDRX annual CFI is now -102.73% below its all-time high of $12.06 million, reached on December 1, 2018.
Performance
BDRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BDRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.0% | - | - |
| 3 y3 years | -110.0% | - | - |
| 5 y5 years | -102.7% | - | - |
BDRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.0% | +13.8% | ||||
| 5 y | 5-year | -110.0% | +93.2% | ||||
| alltime | all time | -102.7% | +93.2% |
Biodexa Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$329.70 K(+21.0%) | - | - |
| Dec 2022 | -$272.40 K(-28.8%) | - | - |
| Dec 2021 | -$382.50 K(-111.6%) | - | - |
| Dec 2020 | $3.30 M(-168.0%) | - | - |
| Dec 2019 | -$4.86 M(-140.3%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $12.06 M(-735.6%) | - | - |
| Dec 2017 | -$1.90 M(+16.5%) | - | - |
| Dec 2016 | -$1.63 M(-30.5%) | - | - |
| Dec 2015 | -$2.34 M(+56.7%) | - | - |
| Dec 2014 | -$1.50 M(+1811.9%) | - | - |
| Dec 2013 | -$78.20 K | - | - |
FAQ
- What is Biodexa Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual CFI year-on-year change?
What is Biodexa Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of BDRX is -$329.70 K
What is the all time high annual CFI for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual cash flow from investing activities is $12.06 M
What is Biodexa Pharmaceuticals annual CFI year-on-year change?
Over the past year, BDRX annual cash flow from investing activities has changed by -$57.30 K (-21.04%)